Details of the Drug

General Information of Drug (ID: DMZL5SB)

Drug Name

DF6002

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Recombinant?protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04423029) Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications. U.S. National Institutes of Health.